Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K113757
    Date Cleared
    2012-02-22

    (63 days)

    Product Code
    Regulation Number
    870.5150
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K061958, K051193, K063371, K071529, K080901

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Aspire MAX 5 and MAX 6 Aspiration Catheters and Aspirator are indicated for the removal of fresh, soft emboli and thrombi from vessels in the peripheral vasculature.

    Device Description

    An Aspire MAX Aspiration Catheter includes (1) Aspire MAX 6 Aspiration Catheter and (1) Aspirator 30ml. Aspire MAX Aspiration Catheters and MAX Aspiration Catheters are single-use, sterile, short-term use, and non-pyrogenic medical devices designed for use with manually operated piston syringes to remove fresh, soft emboli and thrombi from the peripheral and coronary vasculature. The Aspire MAX Aspiration Catheter operating and scientific principle is the same as predicate devices. The catheter is inserted into the body over a guidewire and through a sheath or guide catheter to the target anatomy. A piston syringe is then connected to the catheter and the aspiration is manually created with the piston syringe.

    Similar to predicate devices, industry standard intravascular catheter components and materials are used:

    • Clear proximal polycarbonate female luer lock,
    • -Stainless steel braid,
    • Clear Pebax and Vestamid Shafts, -
    • -Embedded platinum iridium radiopaque marker,
    • Clear polycarbonate barrel piston syringe. -

    Aspire MAX Aspiration Catheters do not add any new materials, manufacturing processes, colorants, or dyes to the manufacturing process.

    Same as predicates, all MAX Aspiration Catheters may be connected to piston syringes including the Aspire Aspirator. Aspirators may be connected to other aspiration catheters.

    AI/ML Overview

    The provided document is a 510(k) Premarket Notification from the U.S. Food and Drug Administration (FDA) for the Aspire MAX Aspiration Catheter. This document focuses on demonstrating substantial equivalence to predicate devices rather than proving a new device's absolute safety and effectiveness through extensive clinical trials as would be required for a PMA (Premarket Approval) device. Therefore, the information provided for acceptance criteria and study that proves the device meets the acceptance criteria is framed within the context of substantial equivalence testing and non-clinical performance, rather than a clinical study with human patients.

    Based on the document, here's a breakdown of the requested information:

    Acceptance Criteria and Device Performance (Non-Clinical)

    The document does not present a formal table of "acceptance criteria" with specific quantitative thresholds for clinical performance metrics (e.g., sensitivity, specificity, or clinical outcome improvements). Instead, the acceptance criteria are implicit in demonstrating substantial equivalence to legally marketed predicate devices through a series of non-clinical tests and comparisons of design, materials, and operating principles.

    The "Device Performance" is demonstrated by passing these non-clinical tests, indicating the device functions as intended and is comparable to predicate devices.

    Table of Comparison (derived from the document):

    Feature/Test CategoryAcceptance Criterion (Implicit for Substantial Equivalence)Reported Device Performance
    ScienceEquivalent Scientific Principle, Mechanism of Use"The Aspire MAX Aspiration Catheter operating and scientific principle is the same as predicate devices."
    Device ConstructionEquivalent Design & Dimensions, Function, Materials"Similar to predicate devices, industry standard intravascular catheter components and materials are used: Clear proximal polycarbonate female luer lock, Stainless steel braid, Clear Pebax and Vestamid Shafts, Embedded platinum iridium radiopaque marker, Clear polycarbonate barrel piston syringe." "Aspire MAX Aspiration Catheters do not add any new materials, manufacturing processes, colorants, or dyes to the manufacturing process."
    ManufacturingConsistent with predicates (e.g., ISO compliant)"Manufacturing extrusion, molding, and assembly in ISO 14644 Class 8 certified clean room is the same as predicates."
    Device Performance (Non-Clinical Tests)Satisfactory performance in various integrity, aspiration, and functional tests"Non-clinical testing confirms the Aspiration Catheters and Aspirator passes all testing and meets specifications." "Subject devices passed all biocompatible tests performed by Ethox and Nelson Labs." "Subject devices passed [particulate tests] with scores significantly below an established minimum national standard."
    - Bend & TorqueAcceptable performanceConfirmed by "Non-Clinical Testing" passing.
    - AspirationEffective aspiration compared to predicates with various aspirants (low/high viscosity, Newtonian/Non-Newtonian), thrombus, in-vivo aspiration.Passed, specifically listed tests include: "MAX Aspiration Catheters and predicates with standard syringes and aspirators with low viscosity aspirants," "MAX Aspiration Catheters and predicates with standard syringes and aspirators with high viscosity Newtonian aspirants," "MAX Aspiration Catheters and predicates with standard syringes and aspirators with high viscosity Non-Newtonian aspirants," "Thrombus aspiration," "In-vivo aspiration."
    - Break strength integrityAcceptable strengthConfirmed by "Non-Clinical Testing" passing.
    - Freedom from Leakage (Aspiration/Injection)No leakageConfirmed by "Non-Clinical Testing" passing.
    - TrackingAcceptable tracking through vesselsConfirmed by "Non-Clinical Testing" passing.
    LabelingEquivalent Indications for Use, Intended Use, Contraindications, Instructions for Use, Warnings"The indication and intended use is substantially equivalent other thrombus aspiration catheters manually actuated by syringes and legally marketed under the DXE product code."
    BiocompatibilityComplies with ISO 10993 and FDA guidance"Biocompatibility: Compliance with 'Required Biocompatibility Training and Toxicology Profiles for Evaluation of Medical Device...' and ISO 10993. Subject devices passed all biocompatible tests performed by Ethox and Nelson Labs."
    SterilizationValidated methods"Sterilization" methods are compared and confirmed to be the same as predicates. "AAMI/ANSI/ISO 11135:1994 Medical Devices - Validation and Routine Control of Ethylene Oxide Sterilization" is cited.

    Study Details:

    This submission relies on non-clinical testing to demonstrate substantial equivalence, not a clinical study. Therefore, some of the requested information (like expert consensus for ground truth or MRMC studies) is not applicable in this context.

    1. Sample size used for the test set and the data provenance:

      • The document does not explicitly state "sample sizes" in terms of number of devices tested for each non-clinical test. It states "Non-clinical testing confirms the Aspiration Catheters and Aspirator passes all testing and meets specifications."
      • Data Provenance: The tests were conducted as part of the regulatory submission process for the device manufacturer, Control Medical Technology. The location of the testing facilities (e.g., Ethox and Nelson Labs mentioned for biocompatibility) would likely be in the US, but this is not explicitly stated as the origin of data.
      • Retrospective or Prospective: The testing was prospective, specifically conducted for this 510(k) submission.
    2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

      • Not applicable. This was a non-clinical testing submission for substantial equivalence. "Ground truth" in this context refers to the defined specifications and parameters of the tests (e.g., tensile strength, aspiration volume, particulate limits) which are derived from industry standards (e.g., ISO, AAMI) and predicate device characteristics, not expert clinical consensus on patient data.
    3. Adjudication method (e.g. 2+1, 3+1, none) for the test set:

      • Not applicable. As this was non-clinical testing, there was no adjudication of expert opinions. Test results are objectively measured against defined specifications.
    4. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

      • Not applicable. This is a medical device (catheter and aspirator), not an AI/imaging device, and no clinical study was performed. The concept of "human readers" and "AI assistance" is not relevant to this submission.
    5. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

      • Not applicable. This is a physical medical device.
    6. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):

      • The "ground truth" for this 510(k) submission is established by engineering specifications, performance metrics derived from industry standards (ISO), and the characteristics of predicate devices that have already been legally marketed. For example, catheter dimensions, material properties, aspiration volume, and leak integrity are measured and compared against established parameters or the performance of predicate devices.
    7. The sample size for the training set:

      • Not applicable. This is not an AI/machine learning device that involves a training set. The device design and manufacturing process are established through engineering and validated through non-clinical testing.
    8. How the ground truth for the training set was established:

      • Not applicable. No training set was involved.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1